Atrial Fibrillation Characteristics in Patients on Haemodialysis vs. Peritoneal Dialysis

被引:11
作者
Abuhasira, Ran [1 ,2 ]
Mizrakli, Yuval [1 ,2 ]
Shimony, Avi [3 ,5 ]
Novack, Victor [2 ,5 ]
Shnaider, Alla [4 ,5 ]
Haviv, Yosef S. [4 ,5 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Joyce & Irving Goldman Med Sch, Beer Sheva, Israel
[2] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel
[3] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel
[4] Soroka Univ, Med Ctr, Dept Nephrol, Beer Sheva, Israel
[5] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
STAGE RENAL-DISEASE; RISK-FACTORS; STROKE; INSIGHTS; WARFARIN;
D O I
10.1038/s41598-018-21229-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Atrial fibrillation (AF) is highly prevalent in dialysis patients, however whether its impact differs between patients on haemodialysis (HD) vs. peritoneal dialysis (PD) is unknown. We aimed to compare the association of AF and clinical outcomes in different dialysis modalities. We performed a population based retrospective cohort study, including adult patients who initiated dialysis between the years 2002 and 2015. Clinical, echocardiographic and laboratory data were reviewed and correlated with outcomes in HD vs. PD. During the study period, 1,130 patients began dialysis. Of the 997 patients without AF before dialysis initiation, 17% developed new-onset AF after the initiation of dialysis (17.3% of HD vs. 13.7% of PD patients, p = 0.27). Using multivariate analysis, only enlarged left atrium at dialysis initiation (hazard ratio (HR) 2.82, CI95% 2.00-3.99) and age (HR 1.04, CI95% 1.03-1.06) were significantly associated with AF. Dialysis modality was not a significant predictor of AF in either univariate or multivariate analysis. In conclusion, our study demonstrated that AF is common in dialysis patients irrespective of modality. In our cohort, the risk factors associated with AF were older age and enlarged left atrium. AF was associated with increased rates of heart failure and mortality, but not stroke.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation
    Suzuki, Tsuyoshi
    Shiga, Tsuyoshi
    Omori, Hisako
    Tatsumi, Fujio
    Nishimura, Katsuji
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 238 - 243
  • [42] Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis
    Mu, Guangyan
    Zhang, Hanxu
    Liu, Zhiyan
    Xie, Qiufen
    Zhou, Shuang
    Wang, Zining
    Wang, Zhe
    Hu, Kun
    Hou, Jingyi
    Zhao, Nan
    Xiang, Qian
    Cui, Yimin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (02) : 181 - 190
  • [43] Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis
    Algethami, Abdulaziz
    Ahmed, Amjad M. A.
    Ardah, Husam
    Alsalamah, Seham
    Alhabs, Ghadah
    Al Fraihi, Ghadah
    Alanazi, Shahad
    Alharbi, Hend
    Aljizeeri, Ahmed
    BIOMEDICINES, 2025, 13 (02)
  • [44] The impact of haemodialysis on the outcomes of catheter ablation in patients with paroxysmal atrial fibrillation
    Takigawa, Masateru
    Kuwahara, Taishi
    Takahashi, Atsushi
    Kobori, Atsushi
    Takahashi, Yoshihide
    Okubo, Kenji
    Watari, Yuji
    Sugiyama, Tomoyo
    Kimura, Shigeki
    Takagi, Katsumasa
    Hikita, Hiroyuki
    Hirao, Kenzo
    Isobe, Mitsuaki
    EUROPACE, 2014, 16 (03): : 327 - 334
  • [45] Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry
    An, Yoshimori
    Ogawa, Hisashi
    Yamashita, Yugo
    Ishii, Mitsuru
    Iguchi, Moritake
    Masunaga, Nobutoyo
    Esato, Masahiro
    Tsuji, Hikari
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Lip, Gregory Y. H.
    Akao, Masaharu
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2019, 5 (01) : 35 - 42
  • [46] Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis
    Surendra, Naren Kumar
    Manaf, Mohd Rizal Abdul
    Hooi, Lai Seong
    Bavanandan, Sunita
    Nor, Fariz Safhan Mohamad
    Khan, Shahnaz Shah Firdaus
    Ong, Loke Meng
    Gafor, Abdul Halim Abdul
    BMC NEPHROLOGY, 2019, 20 (1)
  • [47] Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
    Hernandez, Adrian, V
    Bradley, George
    Khan, Mohammad
    Fratoni, Andrew
    Gasparini, Anna
    Roman, Yuani M.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Coleman, Craig, I
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020, 6 (04) : 301 - 307
  • [48] Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
    Genovesi, Simonetta
    Rossi, Emanuela
    Gallieni, Maurizio
    Stella, Andrea
    Badiali, Fabio
    Conte, Ferruccio
    Pasquali, Sonia
    Bertoli, Silvio
    Ondei, Patrizia
    Bonforte, Giuseppe
    Pozzi, Claudio
    Rebora, Paola
    Valsecchi, Maria Grazia
    Santoro, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (03) : 491 - 498
  • [49] Trends in the Incidence of Atrial Fibrillation in Older Patients Initiating Dialysis in the United States
    Goldstein, Benjamin A.
    Arce, Cristina M.
    Hlatky, Mark A.
    Turakhia, Mintu
    Setoguchi, Soko
    Winkelmayer, Wolfgang C.
    CIRCULATION, 2012, 126 (19) : 2293 - +
  • [50] Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
    Shah, Mitesh
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia A.
    Essebag, Vidal
    Eisenberg, Mark J.
    Rahme, Elham
    Humphries, Karin H.
    Tu, Jack V.
    Behlouli, Hassan
    Guo, Helen
    Pilote, Louise
    CIRCULATION, 2014, 129 (11) : 1196 - 1203